Clinical Trials · NCT04225221

Neurobiology of Bulimia Nervosa

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of North Carolina, Chapel Hill
Enrollment
10
Start date
Feb 2020
Locations
1 site, United States
Primary endpoint
Change in Binge Eating Sum Score
View Gonadorelin compound reference